Xconomy National

Archives

by in
Entry Author Date Location
Editor’s Picks: Xconomy Boston’s Top 20 Stories of the Third Quarter Gregory T. Huang 10/28/11 Boston
Stem Cell Therapy: A Process With a Promise Drew McUsic 10/10/11 Seattle
Biogen Confirms Cambridge Move, Amag Merges With Allos, ACT Kicks Off Trials, & More Boston-Area Life Sciences News Erin Kutz 07/22/11 Boston
Advanced Cell Technology Starts Human Trials of Embryonic Stem Cells Under Strict FDA Supervision Arlene Weintraub 07/20/11 Boston
Advanced Cell Technology Betting Future on Embryonic Stem Cell Therapy for Eye Disease Ryan McBride 12/16/09 Boston
5AM Gathers $200M Fund, Advanced Cell Technology Advances with $2.8 Million, Gloucester Picked up for $640M, & More Boston-Area Deals News Rebecca Zacks 12/11/09 Boston
Advanced Cell Gets $2.8M Luke Timmerman 12/07/09 Boston
Advanced Cell Technology Lands $2,770,000 New Funding Round VentureDeal 12/07/09 Boston
ACT to Vacate Facilities in Boston and California Ryan McBride 09/10/08 Boston
ACT Licences Pluropotent Cell IP Ryan McBride 08/21/08 Boston
Daily TIPs: Blood from Stem Cells, Dems on the Internet, Bright Lights and Windmills, & More Neil Savage 08/20/08 National
ACT, R.I.P? Luke Timmerman 07/17/08 Boston
ACT Creates Stem Cells, Spares Embryos Henry Johnson 01/10/08 Boston
Page 1 of 1
    

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York and beyond.

© 2007-2012, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Site produced by Andrew Koyfman with design from Rob Hunter.